https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210169940%22.PGNR.&OS=DN/20210169940&RS=DN/20210169940
Mesoblast Files U.S. Patent Application Titled ‘METHODS OF TREATING OR PREVENTING NEUROLOGICAL DISEASES’
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.html&r=1&f=G&l=50&s1=%2220210169940%22.PGNR.&OS=DN/20210169940&RS=DN/202
Related Posts
Canaccord Genuity Upgrades BigCommerce Holdings to Buy, Announces $70 Price Target
Today, 10:40 PM
Canaccord Genuity analyst David Hynes upgrades BigCommerce Holdings (NASDAQ:BIGC) from Hold to Buy and announces $70 price target.
Citigroup Maintains Neutral on Workday, Raises Price Target to $203
Today, 10:40 PM
Citigroup analyst Steven Enders maintains Workday (NASDAQ:WDAY) with a Neutral and raises the price target from $185 to $203.
Stellantis Reports Strong 1H Results; Raises FY21 Adjusted Operating Income Margin Outlook
Today, 10:40 PM
Stellantis NV (NYSE:STLA) reported the first half FY21 Pro Forma net revenue growth of 45.8% year-on-year, to €75.3 billion. On Pro…